JH295 is a potent, irreversible, and selective NIMA-related kinase 2 (Nek2) inhibitor with a reported IC50 of approximately 770 nM. The compound alkylates a cysteine residue (Cys22) in Nek2 and contains an alkyne functional group that enables copper-catalyzed azide-alkyne cycloaddition for bioconjugation. It is supplied as a research reagent for biochemical assays, cellular target validation, and chemical biology applications.
- Irreversible Nek2 inhibition via cysteine alkylation.
- Reported IC50 approximately 770 nM.
- Contains an alkyne for click-chemistry conjugation (CuAAC).
- High reported purity (~98.7%).
- Suitable for biochemical assays and chemical biology applications.